Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Edoardo
    Junior Member
    • Mar 2016
    • 2

    #1

    Problem using SnpEff after Transdecoder: large number of warnings

    Hi,
    I am a PhD student with very little experience in bioinformatics (or very little experience at all, I started two months ago).
    I’m having some problems getting Snpeff to work with gff coordinates obtained by Transdecoder.
    I was given by a group with which I am collaborating the assembly of a genome and a gtf file with transcript information derived from RNAseq. I used Transdecoder following the instructions, with the –single_best_orf option, and I got the cds file and a gff3.
    I used the gff3 to build a database for snpeff, because I have to evaluate the effect of some SNPs on the genome. Howevere, when I launched Snpeff eff, I received a great number of warnings:

    INFO_REALIGN_3_PRIME 1
    WARNING_TRANSCRIPT_NO_START_CODON 202855
    WARNING_TRANSCRIPT_NO_START_CODON&INFO_REALIGN_3_PRIME 2
    WARNING_TRANSCRIPT_NO_STOP_CODON 17281

    Protein coding transcripts : 2426
    # Length errors : 0 ( 0,00% )
    # STOP codons in CDS errors : 0 ( 0,00% )
    # START codon errors : 686 ( 28,28% )
    # STOP codon warnings : 183 ( 7,54% )
    # UTR sequences : 2409 ( 99,30% )
    # Total Errors : 686 ( 28,28% )

    Given the low number of transcripts, this amount of warnings seems to be extremely high. Is it normal?
    Also, I checked the CDSs obtained by Transdecoder and, even if not all of them start with ATG, all of them have a start codon near the beginning of the sequence, so I really cannot explain this number of warnings.
    Do you have any suggestions?
    May the life of he/she who comes to my aid be filled with cakes and pizzas.
    Best Regards
    Edoardo

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...